Product Information

NICARDIPINE 30 MG CAPSULE is a generic product labeled by Burel Pharmaceuticals, LLC, priced at $3.9440 per EA under NDC 35573045885. Its NADAC has been published 83 times since Dec 18, 2024.

FDA first approved this application on Jul 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NICARDIPINE 30 MG CAPSULE

nicardipine hydrochloride
$3.9440per EA

Strength

30 mg/1

NDC

35573045885

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/23/2025

Active Ingredients

NICARDIPINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215377

FDA Approved

7/17/2023

TE Code

AB

On Market Since

1/8/2023

Pharmacological Classes

Calcium Channel Antagonists
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for NICARDIPINE 30 MG CAPSULE has been published 83 times since Dec 18, 2024, and over the history we have for it it has risen 19.4%. The table below summarizes its recorded NADAC range and movement.

Current price$3.9440 per EA
All-time high$3.9440 (Jul 15, 2026)
All-time low$3.3006 (Jan 22, 2025)
52-week high$3.9440
52-week low$3.9440
Median price$3.9440
Average price$3.8057
Largest weekly change+6.0% (Apr 23, 2025)
Weeks tracked83
Tracking sinceDec 18, 2024

Price History

1W

N/A

1M

N/A

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+19.4%

Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the nicardipine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of NICARDIPINE 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 30 MG CAPSULE, manufactured by Burel Pharmaceuticals, LLC, is $3.9440 per EA (NDC 35573045885), effective Jul 15, 2026.

How has the price of NICARDIPINE 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for NICARDIPINE 30 MG CAPSULE has risen 19.4%. It has been tracked across 83 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for NICARDIPINE 30 MG CAPSULE?

Since Dec 18, 2024, the NADAC for NICARDIPINE 30 MG CAPSULE has ranged from a low of $3.3006 (Jan 22, 2025) to a high of $3.9440 (Jul 15, 2026), with a median of $3.9440 per EA.

Are there cheaper alternatives to NICARDIPINE 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of NICARDIPINE 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NICARDIPINE 30 MG CAPSULE?

NICARDIPINE 30 MG CAPSULE (NDC 35573045885) is labeled by Burel Pharmaceuticals, LLC, and CMS classifies it as a generic product.